603351.SS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 10:00):

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China...

Stats
Šios dienos apimtis	1.09M
Vidutinė apimtis	525 199
Rinkos kapitalizacija	3.43B
EPS	CNY0.190 ( 2023-10-30 )
Kita pelno data	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	37.00
ATR14	CNY0.0140 (0.05%)

Tūris Koreliacija

Ilgas: 0.32 (neutral)

Trumpas: 0.53 (weak)

Signal:(48.136) Neutral

Nanjing Well Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nanjing Well Koreliacija - Valiuta/Žaliavos

0.47
( neutral )

-0.24
( neutral )

0.00
( neutral )

0.16
( neutral )

-0.06
( neutral )

-0.20
( neutral )

Nanjing Well Finansinės ataskaitos

Annual	2023
Pajamos:	CNY1.16B
Bruto pelnas:	CNY316.80M (27.41 %)
EPS:	CNY0.830

FY	2023
Pajamos:	CNY1.16B
Bruto pelnas:	CNY316.80M (27.41 %)
EPS:	CNY0.830

FY	2022
Pajamos:	CNY1.11B
Bruto pelnas:	CNY303.05M (27.28 %)
EPS:	CNY0.720

FY	2021
Pajamos:	CNY1.04B
Bruto pelnas:	CNY294.39M (28.24 %)
EPS:	CNY0.780

Financial Reports:

No articles found.

Nanjing Well

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. It also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. The company was founded in 2000 and is based in Nanjing, China.